JP2021530440A5 - - Google Patents
Info
- Publication number
- JP2021530440A5 JP2021530440A5 JP2020567854A JP2020567854A JP2021530440A5 JP 2021530440 A5 JP2021530440 A5 JP 2021530440A5 JP 2020567854 A JP2020567854 A JP 2020567854A JP 2020567854 A JP2020567854 A JP 2020567854A JP 2021530440 A5 JP2021530440 A5 JP 2021530440A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- oxavorinin
- benzo
- dihydro
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1809378.1A GB201809378D0 (en) | 2018-06-07 | 2018-06-07 | Novel compounds |
| GB1809378.1 | 2018-06-07 | ||
| PCT/EP2019/064599 WO2019234075A1 (en) | 2018-06-07 | 2019-06-05 | Novel benzimidamides compounds comprising an oxaborinin ring |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530440A JP2021530440A (ja) | 2021-11-11 |
| JP2021530440A5 true JP2021530440A5 (enExample) | 2022-06-09 |
| JP7317866B2 JP7317866B2 (ja) | 2023-07-31 |
Family
ID=62975712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567854A Active JP7317866B2 (ja) | 2018-06-07 | 2019-06-05 | オキサボリニン環を含む新規ベンズイミドアミド化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11352372B2 (enExample) |
| EP (1) | EP3802550B1 (enExample) |
| JP (1) | JP7317866B2 (enExample) |
| KR (1) | KR102661802B1 (enExample) |
| CN (2) | CN116217603A (enExample) |
| BR (1) | BR112020024740A2 (enExample) |
| ES (1) | ES2973710T3 (enExample) |
| GB (1) | GB201809378D0 (enExample) |
| WO (1) | WO2019234075A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| GB201809378D0 (en) * | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| PH12022550646A1 (en) | 2019-09-18 | 2023-04-03 | Genentech Inc | Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2343304B1 (en) | 2005-02-16 | 2015-06-10 | Anacor Pharmaceuticals, Inc. | Biocidal boronophthalide compounds |
| HRP20160569T1 (hr) | 2007-12-03 | 2016-07-29 | Obe Therapy Biotechnology | Boropeptidni inhibitori enteropeptidaze i njihove uporabe u liječenju pretilosti, pretjerane tjelesne težine i/ili bolesti povezane s abnormalnim metabolizmom masti |
| KR20150065941A (ko) * | 2008-03-06 | 2015-06-15 | 아나코르 파마슈티칼스 인코포레이티드 | 소염제로써 붕소가 함유된 소분자 |
| SI3097085T1 (sl) | 2014-01-23 | 2020-11-30 | Sixera Pharma Ab | Derivati benzoksazinona za zdravljenje kožnih bolezni |
| EP3097084B1 (en) * | 2014-01-23 | 2020-09-30 | Sixera Pharma AB | New kallikrein 7 inhibitors |
| GB201809378D0 (en) * | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
-
2018
- 2018-06-07 GB GBGB1809378.1A patent/GB201809378D0/en not_active Ceased
-
2019
- 2019-06-05 WO PCT/EP2019/064599 patent/WO2019234075A1/en not_active Ceased
- 2019-06-05 ES ES19729249T patent/ES2973710T3/es active Active
- 2019-06-05 US US16/972,732 patent/US11352372B2/en active Active
- 2019-06-05 JP JP2020567854A patent/JP7317866B2/ja active Active
- 2019-06-05 CN CN202310268678.7A patent/CN116217603A/zh active Pending
- 2019-06-05 KR KR1020217000497A patent/KR102661802B1/ko active Active
- 2019-06-05 EP EP19729249.3A patent/EP3802550B1/en active Active
- 2019-06-05 BR BR112020024740-5A patent/BR112020024740A2/pt active Search and Examination
- 2019-06-05 CN CN201980037789.9A patent/CN112236433B/zh active Active
-
2022
- 2022-05-06 US US17/738,097 patent/US11767333B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508749A5 (enExample) | ||
| JP2014502641A5 (enExample) | ||
| JP2017528507A5 (enExample) | ||
| JP2013523733A5 (enExample) | ||
| JP2017528503A5 (enExample) | ||
| CN114072396A (zh) | 作为dna-pk抑制剂的喹啉和噌啉衍生物 | |
| CN113784970A (zh) | Erk抑制剂及其应用 | |
| RU2017127135A (ru) | Терапевтическое средство против рака желчных протоков | |
| JP2015524472A5 (enExample) | ||
| JP2016534063A5 (enExample) | ||
| JP2005506308A5 (enExample) | ||
| JP2016506963A5 (enExample) | ||
| JP2017511794A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| JP2018534288A5 (enExample) | ||
| JP2020502111A5 (enExample) | ||
| JP2019505529A5 (enExample) | ||
| JP2014528464A5 (enExample) | ||
| JP2021530440A5 (enExample) | ||
| JP2017505293A5 (enExample) | ||
| JP2010516702A5 (enExample) | ||
| RU2007101236A (ru) | Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей | |
| JP2016522254A5 (enExample) | ||
| JP2009511450A5 (enExample) |